Clinical Trial Update: Phase III Trial of Vinflunine Plus Best Supportive Care vs. Best Supportive Care in Patients With Transitional Cell Carcinoma (TCC) of the Urothelial Tract [Phase 3]

View source ↗

Summary

Phase III trial evaluating vinflunine plus best supportive care versus best supportive care alone in patients with urothelial tract transitional cell carcinoma …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Urothelial Carcinoma

Drugs mentioned

• Vinflunine (vinflunine)

Snippet

Sponsor: Pierre Fabre Medicament | Conditions: Transitional Cell Carcinoma of the Urothelial Tract, Bladder Cancer | Phase 3 | Status: COMPLETED